InMed’s Neurodegenerative Disease Study Presented at Canadian Neuroscience Meeting
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced… Read More




